Business Context and Reporting Period
This Form 8-K Current Report was filed by Prothena Corporation plc on December 5, 2019, regarding an event that occurred on December 3, 2019. The Company is incorporated in Ireland and its ordinary shares trade on The Nasdaq Global Select Market under the symbol PRTA.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The material change reported is the appointment of Oleg Nodelman to the Board of Directors, effective immediately on December 3, 2019. Mr. Nodelman was not assigned to any Board committees at the time of appointment.
Guidance, Outlook, and Management Commentary
There is no guidance, outlook, or management commentary regarding business operations in this filing. Regarding compensatory arrangements, Mr. Nodelman has declined to receive any compensation for his service as a director. Consequently, he will not receive the cash compensation or stock options typically approved for non-employee board members. The Company has entered into its standard Deed of Indemnification with Mr. Nodelman.
Key Facts for Investor Verification
- Oleg Nodelman was appointed as a director effective December 3, 2019.
- Mr. Nodelman is serving without cash compensation or stock options.
- Mr. Nodelman is not currently a member of any Board committees.
- The filing contains no financial results or operational updates.